Literature DB >> 14984577

Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy.

Lisa C Edsall1, Joseph C English, Mark W Teague, James W Patterson.   

Abstract

BACKGROUND: Calciphylaxis and metastatic calcification are known complications of chronic renal failure. Recently, a sclerosing condition of the skin termed nephrogenic fibrosing dermopathy (NFD) has been described in patients with renal disease, many of whom have undergone hemodialysis and/or renal transplantation. To our knowledge, the simultaneous occurrence of both conditions in the same patient, in the same lesion, has not been previously reported. CASE REPORT: We report the clinical, microscopic, and immunohistochemical features of two patients with chronic renal failure whose lesional skin biopsies showed both subcutaneous calcification and NFD. We consider the possible mechanisms that might explain the coexistence of these two disorders.
RESULTS: Both patients presented with erythematous, indurated skin over the lower extremities. Purpuric, reticulated patches, necrosis, or ulceration were not observed. Microscopic examination showed the characteristic changes of NFD involving dermis and subcutaneous septa. In addition, biopsies of both individuals showed subcutaneous calcification, one in a diffuse distribution and the other involving the walls of subcutaneous vessels, as seen in calciphylaxis. Calcification was not suspected clinically in either case.
CONCLUSIONS: Metastatic calcification or calciphylaxis and NFD can occur simultaneously in patients with chronic renal failure and may be found together in the same lesion. Because subcutaneous calcification may not be suspected clinically in these cases, and in view of the adverse outcomes frequently associated with calciphylaxis, we recommend deep incisional biopsy of patients presenting with the clinical features of NFD. Both the fibrosis and the calcification of chronic renal failure may be related to the activity of transforming growth factor-beta/Smad signaling cascades.

Entities:  

Mesh:

Year:  2004        PMID: 14984577     DOI: 10.1111/j.0303-6987.2004.00169.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  13 in total

Review 1.  Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

Authors:  Alexander R Rosenkranz; Thomas Grobner; Gert J Mayer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 2.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

3.  Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

Authors:  B J Edwards; A E Laumann; B Nardone; F H Miller; J Restaino; D W Raisch; J M McKoy; J A Hammel; K Bhatt; K Bauer; A T Samaras; M J Fisher; C Bull; E Saddleton; S M Belknap; H S Thomsen; E Kanal; S E Cowper; A K Abu Alfa; D P West
Journal:  Br J Radiol       Date:  2014-10       Impact factor: 3.039

4.  Metal deposition in calcific uremic arteriolopathy.

Authors:  Lavanya Amuluru; Whitney High; Kim M Hiatt; James Ranville; Sudhir V Shah; Bilal Malik; Sundararaman Swaminathan
Journal:  J Am Acad Dermatol       Date:  2009-04-29       Impact factor: 11.527

Review 5.  Nephrogenic systemic fibrosis: an emerging entity.

Authors:  Sandip K Saxena; Manjuri Sharma; Mital Patel; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-04-17       Impact factor: 2.370

6.  Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions.

Authors:  Martin A Sieber; Philipp Lengsfeld; Thomas Frenzel; Sven Golfier; Heribert Schmitt-Willich; Fred Siegmund; Jakob Walter; Hanns-Joachim Weinmann; Hubertus Pietsch
Journal:  Eur Radiol       Date:  2008-06-11       Impact factor: 5.315

Review 7.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

Review 8.  Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature.

Authors:  Fabian A Mendoza; Carol M Artlett; Nora Sandorfi; Kevin Latinis; Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Semin Arthritis Rheum       Date:  2006-02       Impact factor: 5.532

Review 9.  Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.

Authors:  Jeffrey P Weigle; Dale R Broome
Journal:  Skeletal Radiol       Date:  2008-03-07       Impact factor: 2.199

10.  Nephrogenic systemic fibrosis: current concepts.

Authors:  Prasanta Basak; Stephen Jesmajian
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.